YIFAN PHARMACEUTICAL(SZ:002019)2022-12-08 09:31Group 1: Company Overview - The company is Zhejiang Hangzhou Xinfuyuan Pharmaceutical Co., Ltd. with stock code 002019 [1] - The investor relations activity took place on November 6, 2014, in Hefei, Anhui Province [2] Group 2: Investor Relations Activity - The event was categorized as an investor reception day, attended by various securities analysts and fund representatives [2] - Key company representatives included the Chairman, General Manager, Deputy General Manager, CFO, and Secretary of the Board [2] Group 3: Policy and Market Impact - Discussion on the potential impact of the National Development and Reform Commission's proposed drug price management reforms on the company [2][3] - The company does not base its development strategy solely on pricing but aims to strengthen its foundation through product diversification and vertical and horizontal industry development [3] Group 4: Future Development Directions - Future focus will be on the integration of pharmaceutical raw materials and products, with potential expansion into the healthcare industry [3] - Plans for overseas product development include product agency, ownership buyouts, and acquisitions of foreign companies [3] Group 5: Market Trends - Current pricing of calcium pantothenate is at a relatively low level, with future price trends difficult to predict; the company will adapt to market conditions [3]